These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17855336)

  • 1. CD4 interacts constitutively with multiple CCR5 at the plasma membrane of living cells. A fluorescence recovery after photobleaching at variable radii approach.
    Baker AM; Saulière A; Gaibelet G; Lagane B; Mazères S; Fourage M; Bachelerie F; Salomé L; Lopez A; Dumas F
    J Biol Chem; 2007 Nov; 282(48):35163-8. PubMed ID: 17855336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 and CCR5 constitutively interact at the plasma membrane of living cells: a confocal fluorescence resonance energy transfer-based approach.
    Gaibelet G; Planchenault T; Mazères S; Dumas F; Arenzana-Seisdedos F; Lopez A; Lagane B; Bachelerie F
    J Biol Chem; 2006 Dec; 281(49):37921-9. PubMed ID: 17035237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV gp120-induced interaction between CD4 and CCR5 requires cholesterol-rich microenvironments revealed by live cell fluorescence resonance energy transfer imaging.
    Yi L; Fang J; Isik N; Chim J; Jin T
    J Biol Chem; 2006 Nov; 281(46):35446-53. PubMed ID: 16963439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time analysis of human immunodeficiency virus type 1 Env-mediated membrane fusion by fluorescence resonance energy transfer.
    Furuta RA; Nishikawa M; Fujisawa J
    Microbes Infect; 2006 Feb; 8(2):520-32. PubMed ID: 16300985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
    Popik W; Alce TM; Au WC
    J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of CD4 and CCR5 in living cells.
    Steffens CM; Hope TJ
    J Virol; 2003 Apr; 77(8):4985-91. PubMed ID: 12663805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
    Hug P; Lin HM; Korte T; Xiao X; Dimitrov DS; Wang JM; Puri A; Blumenthal R
    J Virol; 2000 Jul; 74(14):6377-85. PubMed ID: 10864648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events.
    Steffens CM; Hope TJ
    J Virol; 2004 Sep; 78(17):9573-8. PubMed ID: 15308751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-independent binding of SIV gp120 to rhesus CCR5.
    Martin KA; Wyatt R; Farzan M; Choe H; Marcon L; Desjardins E; Robinson J; Sodroski J; Gerard C; Gerard NP
    Science; 1997 Nov; 278(5342):1470-3. PubMed ID: 9367961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
    Foda M; Harada S; Maeda Y
    Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry.
    Farzan M; Vasilieva N; Schnitzler CE; Chung S; Robinson J; Gerard NP; Gerard C; Choe H; Sodroski J
    J Biol Chem; 2000 Oct; 275(43):33516-21. PubMed ID: 10938094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1.
    Kozak SL; Kuhmann SE; Platt EJ; Kabat D
    J Biol Chem; 1999 Aug; 274(33):23499-507. PubMed ID: 10438529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology.
    Jenkinson S; McCoy DC; Kerner SA; Ferris RG; Lawrence WK; Clay WC; Condreay JP; Smith CD
    J Biomol Screen; 2003 Aug; 8(4):463-70. PubMed ID: 14567799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.
    Staropoli I; Chanel C; Girard M; Altmeyer R
    J Biol Chem; 2000 Nov; 275(45):35137-45. PubMed ID: 10926931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops.
    Kolchinsky P; Kiprilov E; Bartley P; Rubinstein R; Sodroski J
    J Virol; 2001 Apr; 75(7):3435-43. PubMed ID: 11238869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.